Millipore Sigma Vibrant Logo
Formulation
Excipients for Pharma & Biopharma | Lipids | aPEGs | Polymers for Drug Delivery

Drug Delivery

Lipids
SynBiosys®
PLA/PLGA Polymers
Functionalized PEGs

Use of lipids and polymers as excipients allows for more precise control of release kinetics and active targeting, enabling development of drugs requiring fewer injections for enhanced patient comfort and compliance. We offer a range of novel delivery and targeting formulations and customized solutions to meet the specific requirements of your API.


Synthetic Lipids – for improved stability, bioavailability,
safety and therapeutic effect

Lipid-based formulations and lipid nanoparticles are strategies of increasing importance in drug development. We offer both customized and off-the-shelf lipids with optimized stability, solubility and handling characteristics and can supply GMP materials in quantities ranging from grams to tons. If lipid blends are needed, we can provide lyophilization and spray drying.



PLA/PLGA Polymers – for modified release formulations of small
molecules and selected peptides

Our poly lactic acid (PLA) and poly lactic-co-glycolic acid (PLGA) polymers are biocompatible and biodegradable synthetic substances for sustained release of small molecule and selected peptide injectables, allowing optimization and precise control of release kinetics.



Synbiosys® Polymers – for modified release formulations of biologics

Formulating large biological APIs such as proteins and large peptides into long acting sustained release formulations has traditionally been a challenge for the pharma industry.

The SynBiosys® technology platform allows the encapsulation of biological therapeutics and controlled drug release - this helps to eliminate development hurdles.



Customized functionalized PEGs – for improved solubility,
bioavailability and hydrophilicity

With a wide range of polyethylene glycol (PEG) grades in solid, semi-solid and liquid form, we can help simplify your formulation process across a range of applications. Our PEG portfolio can be leveraged to reduce poor solubility, increase bioavailability and improve the hydrophilicity of APIs.